SciELO - Scientific Electronic Library Online

vol.33 issue1Minimally invasive micro surgery for aneurysm of the anterior communicating artery: supra-orbitary lateral approach with intraoperative Fluorescein Angiography author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Revista Medica Herediana

Print version ISSN 1018-130XOn-line version ISSN 1729-214X


BARRIGA-SALAVERRY, Guillermo. Tomographic biomarkers in diabetic macular edema. Rev Med Hered [online]. 2022, vol.33, n.1, pp.56-63.  Epub Mar 31, 2022. ISSN 1018-130X.

Diabetic macular edema (DME) is the leading cause of decreased vision among diabetic patients. It can begin in any of the stages of diabetic retinopathy and be associated with comorbidities that can affect various body systems. Many times, the diabetic patient with macular edema needs multidisciplinary management through which he receives initial care from non-ophthalmologist specialists. There is evidence to support that early diagnosis and prompt treatment of DME can minimize permanent visual loss. Non-ophthalmologist specialists who care for diabetic patients can help to detect the DME that their patient may have early to receive the corresponding ophthalmological care. The purpose of this review is to provide the medical community with information on the contribution of optical coherence tomography in the diagnosis of DME and how to recognize tomographic biomarkers that allow predicting the visual outcome of its treatment.

Keywords : Optical Coherence Tomography; diagnosis; treatment outcome; predictive value of tests; diabetic retinopathy; vision disorders.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )